HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation

600829.SS
HPGC Renmintongtai Pharmaceutical CorporationCN flagShanghai Stock Exchange
8.16
CNY
+0.19
- -
4.73BMarket Cap

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Stock Split History

Learn about HPGC Renmintongtai Pharmaceutical Corporation's most recent 3-for-2 basis stock split on June 14, 2011. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about HPGC Renmintongtai Pharmaceutical Corporation's most recent stock split

Split Date: 2011-06-14
Split Ratio: 3:2
Price Before Split: $19.23
Price After Split: $12.82

Developer API

Get 600829.SS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/600829.SS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.50 times more shares (a 3:2 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of HPGC Renmintongtai Pharmaceutical Corporation's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2011-06-143:2No$19.23$12.82
2004-08-253:2NoN/AN/A
2002-10-233:2NoN/AN/A
2002-07-0213:10NoN/AN/A
1997-07-0711:10NoN/AN/A
1996-06-1711:10NoN/AN/A
1995-05-2911:10NoN/AN/A

About HPGC Renmintongtai Pharmaceutical Corporation

Company overview and industry information

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 3-for-2 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to HPGC Renmintongtai Pharmaceutical Corporation Summary

Last updated: 7/10/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.